Publication Date: 2024-01-22
Practice Area: Patent Litigation
Industry: Biotechnology | Pharmaceuticals
Court: U.S. District Court of Delaware
Judge: District Judge Andrews
Attorneys: For plaintiff: Susan E. Morrison, Casey M. Kraning, Fish & Richardson P.C., Wilmington, DE; Brian D. Coggio, Jeremy T. Saks, Fish & Richardson P.C., New York, NY; Kurt L. Glitzenstein, J. Peter Fasse, Fish & Richardson P.C., Boston, MA, John R. Lane, Fish & Richardson P.C., Houston, TX; Amy M. Dudash, Morgan, Lewis & Bockius LLP, Wilmington, DE; Julie S. Goldemberg, Morgan, Lewis & Bockius LLP, Philadelphia, PA; Janice H. Logan, Morgan, Lewis & Bockius LLP, Washington, DC for plaintiffs.
for defendant: Jack B. Blumenfeld, Derek J. Fahnestock, Morris, Nichols, Arsht & Tunnell LLP, Wilmington, DE; William B. Raich, Michael J. Flibbert, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC; Andrew M. Berdon, Robert B. Wilson, James E. Baker, Anastasia M. Fernands, Laura Fairneny, Quinn Emanuel Urquhart & Sullivan LLP, New York, NY; Molly Moore, Quinn Emanuel Urquhart & Sullivan LLP, Washington, DC; Charles E. Lipsey, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Reston, VA; Steven G. Madison, James Bieber, Quinn Emanuel Urquhart & Sullivan LLP, Los Angeles, CA for defendants.
Case Number: 20-1226-RGA
Merely combining natural gene sequences was insufficient to create a patentable invention.